The Risk of Regional Lymph Node Metastases in Patients with Melanoma Less Than 1.0 Mm Thick: Recommendations for Sentinel Lymph Node Biopsy
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 197 (3) , 403-407
- https://doi.org/10.1016/s1072-7515(03)00432-0
Abstract
Lymphatic mapping and sentinel lymph node biopsy can upstage patients with intermediate thickness (1.0 to 4.0 mm) melanoma. Currently, there are no strict guidelines for sentinel lymph node biopsy in patients with melanoma or =5 years of followup from the date of diagnosis was compared with patients with primary melanoma of similar thickness and similar followup intervals without recurrent disease. A total of 114 patients with primary cutaneous melanoma or =0.8 mm thick provided that the technique would detect metastatic disease years before it becomes clinically evident.Keywords
This publication has 16 references indexed in Scilit:
- Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous MelanomasJournal of Clinical Oncology, 2003
- "Epidemic" of Malignant Melanoma: True Increase or Better Detection?Published by American Medical Association (AMA) ,2002
- Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma GroupThe Journal of Pathology, 2002
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2001
- No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mmMelanoma Research, 2001
- Detection of Occult Melanoma Cells in Paraffin-Embedded Histologically Negative Sentinel Lymph Nodes Using a Reverse Transcriptase Polymerase Chain Reaction AssayJournal of Clinical Oncology, 2001
- Establishing a Standard of Care for the Patient with MelanomaAnnals of Surgical Oncology, 2001
- Thin #1 mm Level III and IV Melanomas Are Higher Risk Lesions For Regional Failure and Warrant Sentinel Lymph Node BiopsyAnnals of Surgical Oncology, 2000
- Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth PhaseAnnals of Surgical Oncology, 2000
- Molecular Staging of Malignant MelanomaJAMA, 1998